Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00072007
Status:
COMPLETED
Last Update Posted:
2012-05-15
First Post:
2003-11-04
Brief Title:
Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLL
Sponsor:
Swiss Group for Clinical Cancer Research
Organization:
Swiss Group for Clinical Cancer Research
Organization Data
Organization:
Swiss Group for Clinical Cancer Research
Class:
OTHER
Study ID:
SAKK 3402
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Swiss Group for Clinical Cancer Research
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None